1. Current Approach to Androgen Deprivation Therapy in Patients With Advanced Prostate Cancer 
Axel Heidenreich 
European Urology Supplements 
Volume 9, Issue 11, Pages (December 2010)
DOI: /j.eursup
Copyright © 2010 European Association of Urology Terms and Conditions

2. Fig. 1
Time trends in prostate-cancer risk stratification according to the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE). Reproduced with permission from Cooperberg et al [5].
European Urology Supplements 2010 9, DOI: ( /j.eursup )
Copyright © 2010 European Association of Urology Terms and Conditions

3. Fig. 2
Kaplan-Meier estimate of overall survival in patients receiving immediate or delayed hormonal therapy following radical prostatectomy. Reproduced with permission from Messing et al [7].
ADT=androgen-deprivation therapy; CI=confidence interval.
European Urology Supplements 2010 9, DOI: ( /j.eursup )
Copyright © 2010 European Association of Urology Terms and Conditions

4. Fig. 3
Kaplan-Meier estimates of cancer-specific survival after surgery according to the number of positive nodes (two or fewer positive nodes vs more than two positive nodes; p<0.001). Reproduced with permission from Briganti et al [10].
European Urology Supplements 2010 9, DOI: ( /j.eursup )
Copyright © 2010 European Association of Urology Terms and Conditions

5. Fig. 4
Overall survival according to prostate-specific antigen (PSA) at the end of a 7-mo induction with androgen deprivation in the Southwest Oncology Group 9346 Trial. Reproduced with permission from Hussain et al [21].
European Urology Supplements 2010 9, DOI: ( /j.eursup )
Copyright © 2010 European Association of Urology Terms and Conditions